# A Multi-center 12-week Study of HMS5552 in T2DM

Study · id `cardio:ct-nct02561338` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02561338](<https://clinicaltrials.gov/study/NCT02561338>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02561338

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 258 participants.

## Technical summary

Registry record NCT02561338. Randomized; quadruple masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2016-09 (actual). Results posted on 2020-03-10.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 258 participants (enrolled count; ClinicalTrials.gov record NCT02561338, source copy `cardio:ctgov-nct02561338-2020-03-10`, retrieved 2026-10-26)
- Start date: 2015-09 (registry gives no type) (ClinicalTrials.gov record NCT02561338, source copy `cardio:ctgov-nct02561338-2020-03-10`, retrieved 2026-10-26)
- Primary completion: 2016-09 (actual) (ClinicalTrials.gov record NCT02561338, source copy `cardio:ctgov-nct02561338-2020-03-10`, retrieved 2026-10-26)
- Completion: 2016-09 (actual) (ClinicalTrials.gov record NCT02561338, source copy `cardio:ctgov-nct02561338-2020-03-10`, retrieved 2026-10-26)
- Results first posted: 2020-03-10 (ClinicalTrials.gov record NCT02561338, source copy `cardio:ctgov-nct02561338-2020-03-10`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02561338, source copy `cardio:ctgov-nct02561338-2020-03-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02561338-2020-03-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Multi-center 12-week Study of HMS5552 in T2DM
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): HMS5552
- Intervention (Drug): HMS5552
- Intervention (Drug): HMS5552
- Intervention (Drug): HMS5552
- Intervention (Other): Placebo
- Lead sponsor: Hua Medicine Limited
- Lead sponsor class: INDUSTRY
- Collaborator: Tigermed Consulting Co., Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Hua Medicine Limited (`cardio:org-hua-medicine-limited`)
- Registry lists this organization as a collaborator: Tigermed Consulting Co., Ltd (`cardio:org-tigermed-consulting-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study (`cardio:pubmed-29735394`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2d182d2c88aa42fe07c10d64c9cfc915c77dfe766afe9da3f3f601c2f34b734c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
